Evaluation of the toxicological safety of erinacine A-enriched Hericium erinaceus in a 28-day oral feeding study in Sprague-Dawley rats

Food and Chemical Toxicology

Volumn 70, Issue , 2014, Pages 61-67

  Li, I Chen ^a   Chen, Yen Lien ^a   Lee, Li Ya ^a   Chen, Wan Ping ^a   Tsai, Yueh Ting ^b   Chen, Chin Chu ^a   Chen, Chin Shuh ^c  

^a Grape King Biotechnology Inc   (Taiwan)

^b Super Laboratory Inc   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Erinacine A; Hericium erinaceus; Safety assessment; Sub acute toxicity

Indexed keywords

ERINACINE A; NATURAL PRODUCT; UNCLASSIFIED DRUG; DITERPENE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HERICIUM ERINACEUS; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; MYCELIUM; NONHUMAN; RAT; REPEATED DRUG DOSE; RISK ASSESSMENT; SYSTEMIC DISEASE; TOXICITY TESTING; AGARICALES; ANIMAL; BASIDIOMYCETES; CHEMISTRY; DRUG SURVEILLANCE PROGRAM; ORAL DRUG ADMINISTRATION; PROCEDURES; SPRAGUE DAWLEY RAT; TOXICITY;

ADMINISTRATION, ORAL; AGARICALES; ANIMALS; BASIDIOMYCOTA; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MYCELIUM; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RATS; RATS, SPRAGUE-DAWLEY; TOXICITY TESTS;

EID: 84901421039     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.04.040     Document Type: Article

References (40)

1. Abdulla M.A., Fard A.A., Sabaratnam V., Wong K.H., Kuppusamy U.R., Abdullah N., Ismail S. Potential activity of aqueous extract of culinary-medicinal Lion's Mane mushroom, Hericium erinaceus (Bull.: Fr.) Pers. (Aphyllophoromycetideae) in accelerating wound healing in rats. Int. J. Med. Mushrooms 2011, 13(1):33-39.
2. Covaceuszach S., Capsoni S., Ugolini G., Spirito F., Vignone D., Cattaneo A. Development of a non invasive NGF-based therapy for Alzheimer's disease. Curr. Alzheimer Res. 2009, 6(2):158-170.
3. Freeman R.S., Burch R.L., Crowder R.J., Lomb D.J., Schoell M.C., Straub J.A., Xie L. NGF deprivation-induced gene expression: after ten years, where do we stand?. Prog. Brain Res. 2004, 146:111-126.
4. Giacobini E., Becker R.E. One hundred years after the discovery of Alzheimer's disease. A turning point for therapy?. J. Alzheimer's Dis. 2007, 12(1):37-52.
5. Hiwatashi K., Kosaka Y., Suzuki N., Hata K., Mukaiyama T., Sakamoto K., Shirakawa H., Komai M. Yamabushitake mushroom (Hericium erinaceus) improved lipid metabolism in mice fed a high-fat diet. Biosci. Biotechnol. Biochem. 2010, 74(7):1447-1451.
6. International, AOAC, 1995. Official Methods of Analysis of AOAC International. AOAC International, Gaithersburg, MD.
7. Kawagishi H., Zhuang C. Compounds for dementia from Hericium erinaceum. Drugs Fut. 2008, 33(2):149-155.
8. Kawagishi H., Ando M., Sakamoto H., Yoshida S., Ojima F., Ishiguro Y., Ukai N., Furukawa S. Hericenones C, D and E, stimulators of nerve growth factor (NGF)-synthesis, from the mushroom Hericium erinaceum. Tetrahedron Lett. 1991, 32(35):4561-4564.
9. Kawagishi H., Ando M., Shinba K., Sakamoto H., Yoshida S., Ojima F., Ishiguro Y., Ukai N., Furukawa S. Chromans, hericenones F, G and H from the mushroom Hericium erinaceum. Phytochem 1992, 32(1):175-178.
10. Kawagishi H., Shimada A., Shirai R., Okamoto K., Ojima F., Sakamoto H., Ishiguro Y., Furukawa S. Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett. 1994, 35(10):1569-1572.
11. Kawagishi H., Shimada A., Hosokawa S., Mori H., Sakamoto H., Ishiguro Y., Sakemi S., Bordner J., Kojima N., Furukawa S. Erinacines E, F, and G, stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett. 1996, 37(41):7399-7402.
12. Kawagishi H., Simada A., Shizuki K., Ojima F., Mori H., Okamoto K., Sakamoto H., Furukawa S. Erinacine D, a stimulator of NGF-synthesis, from the mycelia of Hericium erinaceum. Heterocycl. Commun. 1996, 2(1):51.
13. Khan M.A., Tania M., Liu R., Rahman M.M. Hericium erinaceus: an edible mushroom with medicinal values. J. Compl. Integr. Med. 2013, 10(1):253-258.
14. Kim S.P., Kang M.Y., Kim J.H., Nam S.H., Friedman M. Composition and mechanism of antitumor effects of Hericium erinaceus mushroom extracts in tumor-bearing mice. J. Agric. Food Chem. 2011, 59(18):9861-9869.
15. Kim S.P., Moon E., Nam S.H., Friedman M. Hericium erinaceus mushroom extracts protect infected mice against Salmonella Typhimurium-induced liver damage and mortality by stimulation of innate immune cells. J. Agric. Food Chem. 2012, 60(22):5590-5596.
16. Kim Y.O., Lee S.W., Oh C.H., Rhee Y.H. Hericium erinaceus suppresses LPS-induced pro-inflammation gene activation in RAW264.7 macrophages. Immunopharmacol. Immunotoxicol. 2012, 34(3):504-512.
17. Kim S.P., Nam S.H., Friedman M. Hericium erinaceus (Lion's Mane) mushroom extracts inhibit metastasis of cancer cells to the lung in CT-26 colon cancer-transplanted mice. J. Agric. Food Chem. 2013, 61(20):4898-4904.
18. Kim S.P., Nam S.H., Friedman M. Correction to Hericium erinaceus (Lion's Mane) mushroom extracts inhibit metastasis of cancer cells to the lung in CT-26 colon cancer-transplanted mice. J. Agric. Food Chem. 2014, 62(2). 528-528.
19. Krzyczkowski W., Malinowska E., Suchocki P., Kleps J., Olejnik M., Herold F. Isolation and quantitative determination of ergosterol peroxide in various edible mushroom species. Food Chem. 2009, 113(1):351-355.
20. Krzyczkowski W., Malinowska E., Herold F. Erinacine A biosynthesis in submerged cultivation of Hericium erinaceum: quantification and improved cultivation. Eng. Life Sci. 2010, 10(5):446-457.
21. Lee E.W., Shizuki K., Hosokawa S., Suzuki M., Suganuma H., Inakuma T., Li J., Ohnishi-Kameyama M., Nagata T., Furukawa S., Kawagish H. Two novel diterpenoids, erinacines H and I from the mycelia of Hericium erinaceum. Biosci. Biotechnol. Biochem. 2000, 64(11):2402-2405.
22. Levine B.S. Animal clinical pathology. CRC Handbook of Toxicology 2002, 741-768. CRC Press, USA. second ed. M.J. Derelanko, M.A. Hollinger (Eds.).
23. Li H., See H.J., Moon B.K., Yoo Y.B., Lee C. Neuritogenic activity of hot water extract from Hericium erinaceus. J. Mushroom Sci. Prod. 2013, 11(3):117-123.
24. Lorz C., Mehmet H. The role of death receptors in neural injury. Front. Biosci. (Landmark Ed) 2009, 14:583-595.
25. Ma B.-J., Shen J.-W., Yu H.-Y., Ruan Y., Wu T.-T., Zhao X. Hericenones and erinacines: stimulators of nerve growth factor (NGF) biosynthesis in Hericium erinaceus. Mycology 2010, 1(2):92-98.
26. Madduri S., Papaloizos M., Gander B. Synergistic effect of GDNF and NGF on axonal branching and elongation in vitro. Neurosci. Res. 2009, 65(1):88-97.
27. Mori K., Obara Y., Hirota M., Azumi Y., Kinugasa S., Inatomi S., Nakahata N. Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biol. Pharm. Bull. 2008, 31(9):1727-1732.
28. Mori K., Inatomi S., Ouchi K., Azumi Y., Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother. Res. 2009, 23(3):367-372.
29. OECD, 2001. Test No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents. OECD Publishing.
30. Schulte-Herbruggen O., Braun A., Rochlitzer S., Jockers-Scherubl M.C., Hellweg R. Neurotrophic factors - a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases?. Curr. Med. Chem. 2007, 14(22):2318-2329.
31. Schulte-Herbruggen O., Jockers-Scherubl M.C., Hellweg R. Neurotrophins: from pathophysiology to treatment in Alzheimer's disease. Curr. Alzheimer Res. 2008, 5(1):38-44.
32. Shackelford C., Long G., Wolf J., Okerberg C., Herbert R. Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies. Toxicol. Pathol. 2002, 30(1):93-96.
33. Shang X., Tan Q., Liu R., Yu K., Li P., Zhao G.P. In vitro anti-Helicobacter pylori effects of medicinal mushroom extracts, with special emphasis on the Lion's Mane mushroom, Hericium erinaceus (higher Basidiomycetes). Int. J. Med. Mushrooms 2013, 15(2):165-174.
34. Shimbo M., Kawagishi H., Yokogoshi H. Erinacine A increases catecholamine and nerve growth factor content in the central nervous system of rats. Nutr. Res. 2005, 25(6):617-623.
35. Skaper S.D. The biology of neurotrophins, signalling pathways, and functional peptide mimetics of neurotrophins and their receptors. CNS Neurol. Disord.: Drug Targets 2008, 7(1):46-62.
36. Taiwan Food and Drug Administration, 2010. Lists of Raw Materials Suitable for Food Use. Taiwan Food and Drug Administration. < (accessed 04.10.14). https://consumer.fda.gov.tw/Food/Material.aspx?nodeID=160#.
37. Wong K.H., Naidu M., David P., Abdulla M.A., Abdullah N., Kuppusamy U.R., Sabaratnam V. Peripheral nerve regeneration following crush injury to rat peroneal nerve by aqueous extract of medicinal mushroom Hericium erinaceus (Bull.: Fr) Pers. (Aphyllophoromycetideae). Evid. Based Complement Alternat. Med. 2011, 2011:10.
38. Wong J.-Y., Abdulla M.A., Raman J., Phan C.-W., Kuppusamy U.R., Golbabapour S., Sabaratnam V. Gastroprotective effects of Lion's Mane mushroom Hericium erinaceus (Bull.: Fr.) Pers. (Aphyllophoromycetideae) extract against ethanol-induced ulcer in rats. Evid. Based Complement Alternat. Med. 2013, 2013:9.
39. Xu J., Lacoske M.H., Theodorakis E.A. Neurotrophic natural products: chemistry and biology. Angew. Chem. Int. Ed. Engl. 2014, 53(4):956-987.
40. Zhang Z., Lv G., Pan H., Pandey A., He W., Fan L. Antioxidant and hepatoprotective potential of endo-polysaccharides from Hericium erinaceus grown on tofu whey. Int. J. Biol. Macromol. 2012, 51(5):1140-1146.